"I'm wildly bullish, and I may be dead wrong, but I'm wildly bullish."
Law Offices of Howard G. Smith announces that a class action lawsuit has been filed on behalf of investors who purchased Humacyte, Inc. (“Humacyte” or the “Company”) HUMA securities between May 10, 2024 and October 17, 2024, inclusive (the “Class Period”). Humacyte investors have until …
NVIDIA Corporation’s NVDA graphic processing units (GPU) were once sought-after among gamers but are now the key players in the artificial intelligence (AI) market, leading to the company being added to the Dow Jones Industrial Average. Does this make NVIDIA an enticing buy, or is …
The S&P 500 is rallying toward a 25% increase this year, and many growth stocks have greatly contributed to the gain. The one that stands out, though, is Nvidia (NASDAQ: NVDA). It’s become a stock market star thanks to its leadership in the artificial intelligence …
Nuclear energy stocks and ETFs have come to the fore as ARK Invest’s founder Cathie Wood reshared the firm’s study on how regulatory hurdles and anti-nuclear sentiment have caused cost overruns and rendered nuclear energy less cost-competitive than natural gas today. This comes as Tesla …
Shares of BK Technologies Corporation BKTI have gained 19% since the company reported its earnings for the quarter ended Sept. 30, 2024. This contrasts with the S&P 500 index’s -0.7% change over the same time frame. Over the past month, the stock gained 15.5% compared …
Palantir Technologies Inc PLTR has surged over 40% in the past month, 266% YTD, propelled by a series of high-profile partnerships with industry giants like Microsoft Corp, Amazon.com Inc AMZN, and Rio Tinto PLC RIO. The data analytics and AI powerhouse has set a new …
New preclinical results support the anti-fibrotic potential of engineered macrophages in multiple fibrosis models Engineered TIM4-expressing macrophages correct defective efferocytosis in MASH, demonstrating potent anti-fibrotic activity PHILADELPHIA, Nov. 17, 2024 /PRNewswire/ — Carisma Therapeutics Inc. CARM (“Carisma” or the “Company”), a clinical-stage biopharmaceutical company focused on discovering …
Intel (NASDAQ: INTC) was once considered a stable long-term investment on the semiconductor market. But over the past 10 years, the chipmaker’s stock declined 26%. Even with reinvested dividends, it delivered a negative total return of 4%. During the same period, the S&P 500 rallied …
Even though it’s only half over, November has already been a busy month. In addition to the U.S. presidential election and a Federal Reserve meeting that came with another reduction to prime lending rate, companies across all industries have been reporting third-quarter earnings over the …
Quarterly results from Home Depot HD and Disney DIS highlighted this week’s earnings lineup despite the broader market taking a breather following an extensive presidential election rally. However, both were able to exceed earnings expectations making it a worthy topic of whether it’s time to buy stock …